Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

100.0%

4 terminated/withdrawn out of 4 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

4 withdrawn

Enrollment Performance

Analytics

Phase 1
4(100.0%)
4Total
Phase 1(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03976206Phase 1Withdrawn

Very Small Embryonic-like Stem Cells for Facial Skin Antiaging

Role: collaborator

NCT03985462Phase 1Withdrawn

Very Small Embryonic-like Stem Cells for Ovary

Role: collaborator

NCT03973021Phase 1Withdrawn

Very Small Embryonic-like Stem Cells for Erectile Dysfunction

Role: collaborator

NCT03975101Phase 1Withdrawn

Very Small Embryonic-like Stem Cells for Knee Osteoarthritis

Role: collaborator

All 4 trials loaded